Navigation Links
Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions
Date:5/8/2008

3 countries. FLECTOR(R) Patch has been used in more than six million patients with a total of approximately 175 million patches dispensed.

Important Safety Information

Cardiovascular risk

-- NSAIDs may cause an increased risk of serious cardiovascular thrombotic

events, myocardial infarction, and stroke, which can be fatal. This

risk may increase with duration of use. Patients with cardiovascular

disease or risk factors for cardiovascular disease may be at greater

risk.

-- FLECTOR(R) Patch is contraindicated for the treatment of peri-operative

pain in the setting of coronary artery bypass graft (CABG) surgery.

Gastrointestinal risk

-- NSAIDs cause an increased risk of serious gastrointestinal adverse

events including bleeding, ulceration, and perforation of the stomach

or intestines, which can be fatal. These events can occur at any time

during use and without warning symptoms. Elderly patients are at

greater risk for serious gastrointestinal events.

Carefully consider the potential benefits and risks of FLECTOR(R) Patch and other treatment options before deciding to use FLECTOR(R) Patch.

FLECTOR(R) Patch is contraindicated in patients with known hypersensitivity to diclofenac. FLECTOR(R) Patch should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients.

Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals.

FLECTOR(R) Patch should not be applied to non-intact or damaged skin resulting from any etiology, eg, exudative dermatitis, eczema, infected lesion, burns or wounds.

NSAIDs, including FLECTOR(R) Patch, can cause serious skin adverse events such as exfoliative dermatitis, Stevens
'/>"/>

SOURCE Alpharma Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
2. Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology
3. Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
4. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
5. Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections
6. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
7. Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
8. Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch
9. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 Today, Hill-Rom Holdings, Inc. ... regarding progress on significant strategic and financial initiatives ... The Conference is hosted by Peter H. ... include presentations on the following topics: ,, ... research and development and financial updates Smart ...
(Date:12/15/2009)... (Nasdaq: MASI ), the inventor of Pulse ... oximetry, today announced that Masimo Chairman and CEO ... & Sullivan CEO of the Year Award in ... Frost & Sullivan, the award is presented in ... customer requirements, developing new technologies, delivering relevant products, ...
(Date:12/15/2009)... Health, Inc. (Nasdaq: GHDX ) today announced results ... DX® breast cancer test, a multi-gene expression test that ... benefit and recurrence risk for patients with early-stage breast ... CTRC-AACR San Antonio Breast Cancer Symposium, held December 9 ... breadth of data presented at last week,s meeting reflects ...
Breaking Medicine Technology:Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 2Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 3Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 4Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 5Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 6Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 2Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 3Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 4Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 5Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 6Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 7Research proves tai chi benefits for arthritis 49032 1Research proves tai chi benefits for arthritis 49032 2US Farms Inc Launches Aloe Vera Juice Web Site for Hispanic Market 49029 1US Farms Inc Launches Aloe Vera Juice Web Site for Hispanic Market 49029 2US Farms Inc Launches Aloe Vera Juice Web Site for Hispanic Market 49029 3Ambulatory Surgery Centers Pivotal in Moving Outpatient Surgical Services Into Less Expensive Clinically Appropriate Settings 49025 1Ambulatory Surgery Centers Pivotal in Moving Outpatient Surgical Services Into Less Expensive Clinically Appropriate Settings 49025 2Ambulatory Surgery Centers Pivotal in Moving Outpatient Surgical Services Into Less Expensive Clinically Appropriate Settings 49025 3Ambulatory Surgery Centers Pivotal in Moving Outpatient Surgical Services Into Less Expensive Clinically Appropriate Settings 49025 4Ambulatory Surgery Centers Pivotal in Moving Outpatient Surgical Services Into Less Expensive Clinically Appropriate Settings 49025 5
... Keystone Symposia HIV Pathogenesis Conference, SAN ... ANX ) announced that it presented ... product candidate at the,Keystone Symposia HIV Pathogenesis ... The preclinical results demonstrate a unique resistance ...
... ... long-term follow-up, CHICAGO, March 30 Although ... artery disease,many cardiologists choose bare-metal stents for patients with heart attack,or ... drug-eluting stents in this patient group. Such concerns,are being challenged by ...
Other Medicine Technology:ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests 2ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests 3ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests 4Large Study Gives Nod to Drug-Eluting Stents in Heart Attack 2Large Study Gives Nod to Drug-Eluting Stents in Heart Attack 3
(Date:12/15/2009)... Diabetes Association and the CDC have released some sobering statistics concerning ... States. Treadmill desks offer employers an effective means of combating this ... ... December 14, 2009 -- Rates of diabetes are climbing across America ... rates. Despite this rise the American Diabetes Association has stated that ...
(Date:12/15/2009)... Prostate cancer tests promised but not delivered ... Network calls on Congress to ensure that healthcare ... benefit currently required of insurance companies in 37 ... for those segments of the population and individuals ... American men and men who have a family ...
(Date:12/15/2009)... advocates to be leaders in the fight against ... from experts in online learning, the Masie Center ... ONE and Malaria No ... the first-ever "Malaria Griots" program, a dynamic education ... become leaders in the fight against malaria. ...
(Date:12/15/2009)... Dec. 15 Knowledge ... the pharmaceutical and bio-tech research market with ... Over the past 11 years CMR has ... Consulting Network (PCN®), which now includes 70,000 ... both primary care and hard-to-reach specialties. ...
(Date:12/15/2009)... 15 4R Systems, Inc., a leading ... which help retailers significantly increase profits by optimizing ... today that The Vitamin Shoppe has been utilizing ... store and DC inventory solutions have helped us ... in-stocks over the last two years," said Tony ...
Breaking Medicine News(10 mins):Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4
... to those seen in returning Afghanistan war veterans, study ... Workers and volunteers involved in recovery efforts at the ... much higher levels of psychological distress than the general ... mental health questionnaires completed by more than 10,000 World ...
... JOSE, Calif., May 22 VNUS(R) Medical,Technologies, Inc. (Nasdaq: ... the minimally invasive treatment of venous reflux disease, today,announced ... 12th Annual,Spring Investor Conference, to be held May 28-29, ... NY., VNUS, presentation is currently scheduled for 12:50 ...
... Presentation Will be Webcast Live and Archived on ... Vanda Pharmaceuticals,Inc. (Nasdaq: VNDA ), a biopharmaceutical ... product candidates for central,nervous system disorders, today announced ... will deliver a corporate presentation on,Wednesday, May 28, ...
... May 21, 2008 If you were sick, ... specifically for you" Or a treatment that prevents you ... emerging field of clinical and translational science provides the ... therapy. Deputy Editor, Scott A. Waldman, MD, PhD, and ...
... Calif., May 22 AMDL, Inc. (Amex:,ADL), ( ... pharmaceuticals,with operations in Shenzhen, Jiangxi and Jilin, China, ... executive management comments from its Q1,2008 financial results ... corporate website at http://www.amdl.com . Click on ...
... Cheese Containing ... Probiotics & Prebiotic Fiber, JERICHO, N.Y., ... with more healthy benefits hits supermarket shelves --,Friendship All-Natural Digestive ... nutrition and health packed All-Natural,cottage cheese product, Friendship Dairies delivers ...
Other Medicine News:Health News:9/11 Workers Face Chronic Mental Impairment 2Health News:Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference 2Health News:Unlocking the promise of clinical and translational science 2Health News:AMDL Teleconference Available on amdl.com at 5:00 p.m. EDT Today 2Health News:New Friendship Cottage Cheese Boosts Digestive & Bone Health 2Health News:New Friendship Cottage Cheese Boosts Digestive & Bone Health 3
Pilot and control your analysis at a touch. 26 parameters CBC/DIFF with autoloader...
... System is an easy-to-use, workflow-based system designed to ... Inspirex consists of the SleepWorks software and either ... and durable systems can be used for a ... - including full EEG recording - and have ...
... PR 2100 is a compact, stand-alone microprocessor-controlled ... specimens in 96-well microplates using single- or ... (2.7-for dual-wavelength) and a dynamic reading range ... to meet any laboratory or assay requirements. ...
... The VARIANT II™ Total ... fast, totally-automated and objective ... of total glycated hemoglobin ... The results are reported ...
Medicine Products: